Mirum Pharmaceuticals Inc... (MIRM)
NASDAQ: MIRM
· Real-Time Price · USD
67.89
3.06 (4.72%)
At close: Aug 15, 2025, 3:59 PM
67.86
-0.04%
After-hours: Aug 15, 2025, 06:59 PM EDT
Mirum Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 127.78M | 111.58M | 99.41M | 90.38M | 77.88M | 69.22M | 69.55M | 47.73M | 37.5M | 31.6M | 27.91M | 18.78M | 17.48M | 12.89M | 3.14M | 5M | 11M | n/a |
Cost of Revenue | 23.42M | 23.02M | 22.78M | 20.81M | 20.23M | 17.83M | 22.6M | 10.23M | 6.81M | 4.98M | 4.49M | 2.93M | 2.52M | 2.42M | 1.9M | n/a | n/a | 185K |
Gross Profit | 104.36M | 88.57M | 76.63M | 69.57M | 57.65M | 51.39M | 46.95M | 37.5M | 30.68M | 26.62M | 23.41M | 15.85M | 14.96M | 10.47M | 1.24M | 5M | 11M | -185K |
Operating Income | -4.99M | -15.18M | -24.22M | -12.68M | -24.23M | -26.47M | -30.07M | -25.15M | -24.27M | -27.15M | -34.16M | -32.88M | -31.44M | -32.74M | -45.58M | -42.82M | -37.4M | -47.61M |
Interest Income | 3.03M | 3.02M | 3.2M | 3.47M | 3.49M | 3.63M | 3.77M | 4.06M | 3.63M | 2.27M | 2.14M | 1.35M | 293K | 69K | 65K | 72K | 80K | 149K |
Pretax Income | -5.46M | -13.65M | -24.37M | -13.89M | -24M | -24.66M | -32.92M | -23.34M | -73.72M | -29.93M | -36.29M | -35.69M | -33.49M | -36.59M | 57.56M | -47.1M | -43.88M | -50.53M |
Net Income | -5.86M | -14.68M | -23.79M | -14.23M | -24.64M | -25.28M | -33.15M | -23.59M | -74.04M | -30.13M | -36.43M | -35.71M | -26.92M | -36.61M | 57.55M | -47.11M | -43.89M | -50.53M |
Selling & General & Admin | 63.29M | 57.71M | 56.83M | 50.55M | 49.21M | 45.64M | 46.18M | 36.53M | 32.95M | 30.22M | 26.47M | 22.51M | 20.97M | 19.12M | 19.04M | 17.35M | 13.35M | 9.48M |
Research & Development | 46.07M | 46.04M | 44.03M | 31.71M | 32.67M | 32.22M | 30.84M | 26.12M | 22.01M | 23.55M | 31.11M | 26.22M | 25.43M | 24.09M | 27.77M | 30.47M | 35.05M | 38.13M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -192K | n/a | -154K | n/a | -35K | n/a | -16K |
Operating Expenses | 109.35M | 103.75M | 100.86M | 82.25M | 81.88M | 77.86M | 77.03M | 62.65M | 54.96M | 53.77M | 57.57M | 48.73M | 46.4M | 43.2M | 46.81M | 47.82M | 48.4M | 47.61M |
Interest Expense | 3.59M | 3.6M | 3.58M | 3.59M | 3.57M | 3.58M | 3.56M | 3.57M | 3.73M | 4.24M | 4.36M | 3.97M | 3.88M | 3.77M | 3.77M | 5.67M | 4.78M | 3.38M |
Selling & Marketing Expenses | n/a | n/a | -7.97M | n/a | 7.97M | n/a | 6.3M | n/a | 5.68M | n/a | 9.51M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 132.77M | 126.77M | 123.64M | 103.06M | 102.11M | 95.69M | 99.63M | 72.87M | 61.77M | 58.75M | 62.07M | 51.66M | 48.92M | 45.63M | 48.71M | 47.82M | 48.4M | 47.61M |
Income Tax Expense | 402K | 1.03M | -576K | 347K | 635K | 624K | 225K | 249K | 316K | 201K | 140K | 13K | -6.57M | 11K | 12K | 9K | 11K | 5K |
Shares Outstanding (Basic) | 49.73M | 48.89M | 48.34M | 47.78M | 47.24M | 46.93M | 46.72M | 41.1M | 38.11M | 37.68M | 36.96M | 34.93M | 32.16M | 31.3M | 30.32M | 30.37M | 30.27M | 30.11M |
Shares Outstanding (Diluted) | 49.73M | 48.89M | 48.34M | 47.78M | 47.24M | 46.93M | 46.72M | 41.1M | 38.11M | 37.68M | 37.52M | 34.93M | 32.18M | 31.3M | 30.58M | 30.37M | 30.27M | 30.11M |
EPS (Basic) | -0.12 | -0.3 | -0.49 | -0.3 | -0.52 | -0.54 | -0.71 | -0.57 | -1.94 | -0.8 | -0.99 | -1.02 | -0.84 | -1.17 | 1.88 | -1.55 | -1.45 | -1.68 |
EPS (Diluted) | -0.12 | -0.3 | -0.49 | -0.3 | -0.52 | -0.54 | -0.71 | -0.57 | -1.94 | -0.8 | -0.97 | -1.02 | -0.84 | -1.17 | 1.88 | -1.55 | -1.45 | -1.68 |
EBITDA | 4.19M | -4M | -14.73M | -4.25M | -14.58M | -15.41M | -26.38M | -17.1M | -68.51M | -24.21M | -30.6M | -30.52M | -28.91M | -32.38M | 61.76M | -41.25M | -38.93M | -46.96M |
EBIT | -1.87M | -10.05M | -20.79M | -10.3M | -20.43M | -21.08M | -31.87M | -19.77M | -70M | -25.69M | -31.93M | -31.72M | -29.62M | -32.82M | 61.32M | -41.43M | -39.11M | -47.15M |
Depreciation & Amortization | 6.06M | 6.05M | 6.06M | 6.05M | 5.85M | 5.66M | 5.4M | 2.66M | 1.48M | 1.48M | 1.33M | 1.2M | 705K | 443K | 437K | 178K | 175K | 185K |